Project Grant HT94252510615
Award Date
8/1/25
Completion Date
7/31/27
Dollars Obligated
$153K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Gainesville, FL 32611, USA
Similar Awards
The University of Florida was awarded a $1,166,594 project grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "EARLY CARDIAC BIOMARKERS OF INFLAMMATION AND REMODELING IN DMD," will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The project will investigate innovative approaches to address critical health challenges related...
The University of Florida was awarded a $5.796 million Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of September 1, 2023 through August 31, 2027. The grant will support the development of clinical candidates for the treatment of Myotonic Dystrophy at the University's location in Gainesville, Florida. As the prime awardee, the University will leverage its expertise in biomedical research to...
This Project Grant award of $996,586.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Florida focused on investigating alcohol use as a moderating factor in serotonergic neurodegeneration during the early stages of Alzheimer's disease. The award period runs from May 15, 2025 to May 14, 2028. The University of Florida, a prominent public research university, will conduct this...
The University of Florida was awarded a $304,894 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to develop localized oxygen delivery using silk fibroin-based micro-particles loaded with salmon hemoglobin from March 15, 2021 through March 14, 2023. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
The University of Florida Division of Sponsored Research was awarded a $745,408 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on April 1, 2024, will support research on the "Contribution of Repeat Associated Non-AUG (RAN) Proteins in Friedreich's and Other Hereditary Ataxias" over a 4-year period through March 31, 2028. This research aims to advance the understanding and...
This $377,227 Project Grant was awarded on August 15, 2024 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The prime awardee, Florida State University, will conduct research related to traumatic brain injury and psychological health. The funded project aims to develop innovative...
The University of Florida was awarded a $305,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from March 2021 through March 2024 to develop novel therapies for dystonia. Through this funding, the University of Florida Division of Sponsored Research will conduct research into medical solutions for dystonia that can potentially transform healthcare for service members and the...
This federal Project Grant award of $551,881 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of Florida on a novel therapeutic approach for BRCA-mutated triple-negative breast cancer. The research aims to evaluate the dual inhibition of PARP and IL-6 as a potential treatment. The award period is from July 1, 2024 to June 30, 2027, providing funding to conduct this innovative, multi-year...
The University of Florida was awarded a $482,708 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, which runs from September 30, 2025 to September 29, 2028, will fund research to develop a combined therapeutic approach using acute intermittent hypoxia and respiratory-triggered diaphragm pacing to restore breathing function in individuals with chronic cervical spinal cord injuries. This research aims to transform...
The University of Arizona was awarded a $1,791,407 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "Targeting Drug Resistance in the Bone Microenvironment Using a Novel PIM-PROTAC". The 3-year grant, running from March 1, 2025 to February 29, 2028, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The funding will...